Glucose-regulated protein 78 autoantibody associates with blood-brain barrier disruption in neuromyelitis optica.
Glucose-regulated protein 78 autoantibody associates with blood-brain barrier disruption in neuromyelitis optica.
复制标题
DOI:
10.1126/scitranslmed.aai9111
复制
发表时间:
2017-07-05
影响因子:
17.1
通讯作者:
Bennett JL
中科院分区:
文献类型:
--
作者:
Shimizu F;Schaller KL;Owens GP;Cotleur AC;Kellner D;Takeshita Y;Obermeier B;Kryzer TJ;Sano Y;Kanda T;Lennon VA;Ransohoff RM;Bennett JL
Neuromyelitis optica (NMO) is an inflammatory disorder mediated by antibodies to aquaporin-4 (AQP4) with prominent blood-brain barrier (BBB) breakdown in the acute phase of the disease. Anti-AQP4 antibodies are produced mainly in the periphery, yet they target the astrocyte perivascular end feet behind the BBB. We reasoned that an endothelial cell–targeted autoantibody might promote BBB transit of AQP4 antibodies and facilitate NMO attacks. Using monoclonal recombinant antibodies (rAbs) from patients with NMO, we identified two that strongly bound to the brain microvascular endothelial cells (BMECs). Exposure of BMECs to these rAbs resulted in nuclear translocation of nuclear factor κB p65, decreased claudin-5 protein expression, and enhanced transit of macromolecules. Unbiased membrane proteomics identified glucose-regulated protein 78 (GRP78) as the rAb target. Using immobilized GRP78 to deplete GRP78 antibodies from pooled total immunoglobulin G (IgG) of 50 NMO patients (NMO-IgG) reduced the biological effect of NMO-IgG on BMECs. GRP78 was expressed on the surface of murine BMECs in vivo, and repeated administration of a GRP78-specific rAb caused extravasation of serum albumin, IgG, and fibrinogen into mouse brains. Our results identify GRP78 antibodies as a potential component of NMO pathogenesis and GRP78 as a candidate target for promoting central nervous system transit of therapeutic antibodies.
登录
查看更多内容
影响因子:
11.2
作者:
Bennett, Jeffrey L.;Lam, Chiwah;Kalluri, Sudhakar Reddy;Saikali, Philippe;Bautista, Katherine;Dupree, Cecily;Glogowska, Magdalena;Case, David;Antel, Jack P.;Owens, Gregory P.;Gilden, Don;Nessler, Stefan;Stadelmann, Christine;Hemmer, Bernhard
通讯作者:
Hemmer, Bernhard
影响因子:
9.3
作者:
Jarius S;Franciotta D;Paul F;Ruprecht K;Bergamaschi R;Rommer PS;Reuss R;Probst C;Kristoferitsch W;Wandinger KP;Wildemann B
通讯作者:
Wildemann B
影响因子:
5.8
作者:
Jarius, S.;Wildemann, B.
通讯作者:
Wildemann, B.
DOI:
10.1212/nxi.0000000000000231
发表时间:
2016-06
期刊:
Neurology(R) neuroimmunology & neuroinflammation
影响因子:
--
作者:
Majed M;Fryer JP;McKeon A;Lennon VA;Pittock SJ
通讯作者:
Pittock SJ
影响因子:
3.3
作者:
Burgoon, MP;Williamson, RA;Gilden, DH
通讯作者:
Gilden, DH